Light To Guide Our Feet
Light To Guide Our Feet

Menu

Collapse

Search Result

Collapse

Announcement

Collapse
No announcement yet.

What's Going On

Collapse

There are currently 155 users online. 4 members and 151 guests.

Most users ever online was 3,930 at 06:07 PM on 04-20-2019.

2 results in 0.0074 seconds.
Keywords
Members
Tags
detect x
  •  

  • HHS Supports Mesa Biotech to Develop a Rapid Diagnostic to Detect Novel Coronavirus Infections

    HHS Supports Mesa Biotech to Develop a Rapid Diagnostic to Detect Novel Coronavirus Infections| site |



    (March 18, 2020) - - Today, the U.S. Department of Health and Human Services (HHS) published the following information: In response to the now global pandemic, the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), continues to work with its public-private partners to find solutions to mitigate the public health impact of the coronavirus disease 2019 (COVID-19). Part of this landscape is the immediate need for diagnostics tests that can quickly and accurately diagnose COVID-19 infections in order to identify the virus and mitigate the spread of the disease. BARDA will provide Mesa Biotech, Inc. of San Diego, California, with technical expertise and $561,330 in immediate funding to pursue eventual Food and Drug Administration (FDA) approval or clearance of its dia...
    See more | Go to post

  • FDA Permits Marketing of Artificial Intelligence-based Device to Detect Certain Diabetes-related Eye Problems

    FDA Permits Marketing of Artificial Intelligence-based Device to Detect Certain Diabetes-related Eye Problems



    (April 11, 2018) - - The U.S. Food and Drug Administration (FDA) today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Diabetic retinopathy occurs when high levels of blood sugar lead to damage in the blood vessels of the retina, the light-sensitive tissue in the back of the eye. Diabetic retinopathy is the most common cause of vision loss among the more than 30 million Americans living with diabetes and the leading cause of vision impairment and blindness among working-age adults. “Early detection of retinopathy is an important part of managing care for the millions of people with diabetes, yet many patients with diabetes are not adequately scre...
    See more | Go to post

Menu

Collapse

Trending

Collapse

  • Staff Reporter 1
    HHS Supports Mesa Biotech to Develop a Rapid Diagnostic to Detect Novel Coronavirus Infections
    by Staff Reporter 1
    HHS Supports Mesa Biotech to Develop a Rapid Diagnostic to Detect Novel Coronavirus Infections| site |



    (March 18, 2020) - - Today, the U.S. Department of Health and Human Services (HHS) published the following information: In response to the now global pandemic, the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS Office of the Assistant Secretary for Preparedness and Response (ASPR), continues to work with its public-private partners to find solutions to mitigate the public health impact of the coronavirus disease 2019 (COVID-19). Part of this landscape is the immediate need for diagnostics tests that can quickly and accurately diagnose COVID-19 infections in order to identify the virus and mitigate the spread of the disease. BARDA will provide Mesa Biotech, Inc. of San Diego, California, with technical expertise and $561,330 in immediate funding to pursue eventual Food and Drug Administration (FDA) approval or clearance of its dia...
    03-18-2020, 07:47 PM
  • Staff Reporter 1
    FDA Permits Marketing of Artificial Intelligence-based Device to Detect Certain Diabetes-related Eye Problems
    by Staff Reporter 1
    FDA Permits Marketing of Artificial Intelligence-based Device to Detect Certain Diabetes-related Eye Problems



    (April 11, 2018) - - The U.S. Food and Drug Administration (FDA) today permitted marketing of the first medical device to use artificial intelligence to detect greater than a mild level of the eye disease diabetic retinopathy in adults who have diabetes. Diabetic retinopathy occurs when high levels of blood sugar lead to damage in the blood vessels of the retina, the light-sensitive tissue in the back of the eye. Diabetic retinopathy is the most common cause of vision loss among the more than 30 million Americans living with diabetes and the leading cause of vision impairment and blindness among working-age adults. “Early detection of retinopathy is an important part of managing care for the millions of people with diabetes, yet many patients with diabetes are not adequately scre...
    04-12-2018, 07:28 PM

Menu

Collapse

Menu

Collapse

Working...
X